Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure

Area of Science:

• Cardiology
• Medical Devices
• Clinical Decision-Making

Background:

• Symptomatic heart failure with reduced ejection fraction increases sudden cardiac death risk.
• Implantable cardioverter-defibrillators (ICDs) are used for primary prevention of sudden death.
• Recent trial data informs clinical decisions regarding ICD implantation.

Purpose of the Study:

• To provide practical guidance on implanting ICDs for primary prevention in heart failure.
• To distill recent trial experience for clinical application.
• To aid clinicians in patient selection and communication regarding ICDs.

Main Methods:

• Review and synthesis of recent clinical trial data on ICDs in heart failure.
• Focus on patient selection criteria: LVEF < 30-35% and 1-year survival prognosis.
• Framing patient communication around a 5-year outlook.

Main Results:

• For every 100 patients treated, 7-8 lives are predicted to be saved by ICDs over 5 years.
• Approximately 30 patients are predicted to die within 5 years, irrespective of ICD use.
• Consideration of adverse events like unnecessary shocks and device deactivation.

Conclusions:

• ICD implantation for primary prevention in selected heart failure patients offers significant survival benefits.
• Informed patient selection and clear communication about risks and benefits are crucial.
• The decision-making process should include the possibility of device deactivation for natural death.